glp-1 drugs wegovy Ro Launches Wegovy® Pill Through Integration with Novo Nordisk GLP-1 weight-loss drugs: PA, NJ

With drugs like Ozempic and Wegovy growing in popularity among diabetic patients, CRNAs must be aware of all potential GLP-1 and anesthesia conflicts.

It is comprised of a proprietary blend of plant glycosides to create a unique, full-mouth sweetness similar to that of sugar

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients

Prospective ultrasound studies show a higher prevalence of residual gastric content in GLP-1 RA users, particularly during dose escalation or when GI symptoms are present

The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis

BACKED BY SCIENCE